DYN - Dyne Therapeutics Inc

Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases in the United States. The company is headquartered in Waltham, Massachusetts.

52W High

$37.08

52W Low

$6.36

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.10

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-8.87

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

3.54

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.49%

Institutions (25–75% balanced)

95.45%

Shares Outstanding

142,264,000

Float

122,664,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-3.88

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.61%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.6077

0.6724

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025